On March 25, Indiana Governor Mike Pence signed legislation (Senate Bill 262) that will allow pharmacists in Indiana to substitute an interchangeable biosimilar product for a prescribed biological product if certain conditions are met.  Senate Bill 262, which was authored by Sen. Brandt Hershman (R)…

Read More